Profiel
David W.
Denning was the founder of F2G Ltd. which was founded in 1998, where he held the title of Director.
Mr. Denning is also the founder of Myconostica Ltd. In his former jobs, he held the position of Principal at Stanford University from 1987 to 1990 and at The University of Manchester.
Eerdere bekende functies van David W. Denning
| Bedrijven | Functie | Einde |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1990 |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Oprichter | - |
Myconostica Ltd.
Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops molecular diagnostic fungal testing kits | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myconostica Ltd.
Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops molecular diagnostic fungal testing kits | Electronic Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
















